About [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone
[(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone (PubChem CID 129119330) has the molecular formula C42H61N3O
and a molecular weight of 623.97 g/mol. Its IUPAC name is [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone.
Frequently Asked Questions
What is the IUPAC name of [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone?
The IUPAC name of [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone (CID 129119330) is [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone.
What is the SMILES notation for [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone?
The canonical SMILES for [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone is C=C(C)[C@@H]1CC[C@]2(C(=O)N3CCC[C@H]3c3nc4ccccc4[nH]3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](C)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.
What is the InChIKey of [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone?
The InChIKey is HVJMZTXOEURIHL-SEZQWHMOSA-N. The full InChI is InChI=1S/C42H61N3O/c1-26(2)28-18-22-42(37(46)45-25-11-14-32(45)36-43-30-12-9-10-13-31(30)44-36)24-23-40(7)29(35(28)42)15-16-34-39(6)20-17-27(3)38(4,5)33(39)19-21-41(34,40)8/h9-10,12-13,27-29,32-35H,1,11,14-25H2,2-8H3,(H,43,44)/t27-,28-,29+,32-,33-,34+,35+,39-,40+,41+,42-/m0/s1.
What are the key properties of [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone?
[(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone has a molecular weight of 623.97 g/mol, XLogP of 10.52, 3 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,3aS,5aR,5bR,7aS,9S,11aS,11bR,13aR,13bR)-5a,5b,8,8,9,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]-[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]methanone is sourced from PubChem (CID 129119330), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).